The treatment of patients with non-small cell lung cancer carrying uncommon <i>EGFR</i> mutations, <i>HER2</i> mutations, or brain metastases: a systematic review of pre-clinical and clinical findings for dacomitinib.

Yang, Li-Li; Luo, Xiao-Zhen; Xie, Ling-Ling; Lei, Xiao-Zhen; Zhu, Jiang

The treatment of patients with non-small cell lung cancer carrying uncommon EGFR mutations, HER2 mutations, or brain metastases: a systematic review of pre-clinical and clinical findings for dacomitinib.

Yang, Li-Li; Luo, Xiao-Zhen; Xie, Ling-Ling; Lei, Xiao-Zhen; Zhu, Jiang.

Afiliación

Yang LL; Department of Medical Oncology, Chengdu Shangjinnanfu Hospital, West China Hospital of Sichuan University, Chengdu, China.
Luo XZ; Department of Medical Oncology, Chengdu Shangjinnanfu Hospital, West China Hospital of Sichuan University, Chengdu, China.
Xie LL; Department of Medical Oncology, Chengdu Shangjinnanfu Hospital, West China Hospital of Sichuan University, Chengdu, China.
Lei XZ; Department of Medical Oncology, Chengdu Shangjinnanfu Hospital, West China Hospital of Sichuan University, Chengdu, China.
Zhu J; Department of Medical Oncology, West China Hospital of Sichuan University, Chengdu, China.

Transl Cancer Res ; 12(8): 2197-2211, 2023 Aug 31.

Article en En | MEDLINE | ID: mdl-37701115

Palabras clave

Dacomitinib; brain metastases; lung cancer; uncommon mutations

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Systematic_reviews Idioma: En Revista: Transl Cancer Res Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google